Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence
Heart failure patients within the HM programme
| Condition(s) | Heart Failure |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Heart failure patients within the HM programme |
| Who can participate | Inclusion Criteria: AMPEL, CIP, Version: 1.2 Date: 27.03.2024 1. Written, signed and dated informed consent for inclusion in the HM programme 2. Male and female patients over 18 years of age. 3. Hospitalised for decompensated heart failure requiring intravenous diuretics 4. Need for iv diuresis in nonhospital setting because of impending hospitalization for cardiac decompensation Exclusion Criteria: 1. Multimorbidity (Charlson Comorbidity Index \> 6) 2. Dementia 3. Lack of willingness to participate |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Medical University Innsbruck |
| Locations | Graz, Styria, Austria; Innsbruck, Tyrol, Austria |
| Start date | 2024-12-03 |
| NCT ID | NCT06714344 |
| Official listing | https://clinicaltrials.gov/study/NCT06714344 |